Sun BioPharma, Inc. 4
4 · Sun BioPharma, Inc. · Filed Dec 14, 2016
Insider Transaction Report
Form 4
Kellen Scott
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2016-12-12+150,000→ 150,000 totalExercise: $1.51Exp: 2026-12-12→ Common Stock (150,000 underlying) - Award
Employee Stock Option (right to buy)
2016-12-12+66,000→ 66,000 totalExercise: $1.51From: 2016-12-12Exp: 2026-12-12→ Common Stock (66,000 underlying)
Footnotes (2)
- [F1]Options scheduled to vest in eight equal installments on the last day of each calendar quarter, starting March 31, 2017.
- [F2]On December 12, 2016, the reporting person was granted an option to purchase up to 300,000 shares of common stock. The option vests proportionately based on cash proceeds received by, or contractually obligated to be remitted to, the issuer after June 1, 2016 and before December 31, 2018 from any transaction, excluding certain internal operating-related cash flows. The performance criteria was 22% satisfied on the date of grant, resulting in vesting of the option as to 66,000 shares.